NAFLD in HIV-infected Patients

  • STATUS
    Recruiting
  • participants needed
    400
  • sponsor
    Shanghai Public Health Clinical Center
Updated on 19 February 2024
liver disease
fatty liver

Summary

The prevalence of NAFLD (nonalcoholic fatty liver disease) in HIV-infected patients is higher than that in general population, but the causes of morbidity and pathogenesis have not been fully explored. The investigators are planning to consecutively enroll 400 cases HIV-positive outpatients, and to detect NAFLD by ultrasound. The fecal and blood samples were also collected to explore the mechanism of NAFLD. The investigators aimed to determine the prevalence and risk factors of NAFLD in HIV infected patients.

Details
Condition NAFLD, HIV-infection/Aids
Age 18-70 years
Treatment No intervention; cross-sectional study
Clinical Study IdentifierNCT04215926
SponsorShanghai Public Health Clinical Center
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Age 18~70 y
HIV-positive patients
written the informed consent

Exclusion Criteria

coinfected with HBV, HCV
secondary causes of fatty liver (eg, consumption of amiodarone and tamoxifen) and decompensated liver disease
significant alcohol consumption (>20 g per day for man, >10 g per day for woman)
received antibiotics in preceding two months
autoimmune disease
severe heart, lung, kidney, brain, blood diseases or other important systemic diseases
pregnant or lactating women
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.